Clasado Appoints New Business Development Director

Clasado Biosciences (‘Clasado’), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has appointed Dr Luis Gosálbez as Business Development Director.

The appointment further galvanises the executive team behind Clasado and its unique dietary prebiotic Bimuno®. With a proven track record of success in the life sciences sector, Dr Gosálbez will harness over a decade of industry experience to connect the research and development division with commercial activity, as well as supporting partner businesses and stakeholders.

Tasked with communicating the extensive research behind the prebiotic to Clasado customers, Dr Gosálbez will help steer new strategic business development initiatives and continue to build on the strong partnerships the company has within the industry.

Dr Gosálbez commented: “I am delighted to join the executive team at Clasado during this exciting growth period in the company’s history. As Business Development Director, I look forward to bringing my experience in commercial life sciences to the forefront and developing the strong relationships Clasado has with its partner businesses.

“Bimuno® is truly shaking up the wellness market as gut health becomes front and centre in consumer health and wellbeing understanding. It is an innovative science-backed prebiotic with a great deal of potential across a number of key sectors, also finding application in an ever-growing number of geographies. In my new role, I will further realise this potential and am focussed on opening up new commercial avenues for the product.”

Per Rehné, Clasado CEO, added: “We are delighted to welcome Dr Gosálbez to the Clasado team. A well-known industry figure, his strong background in health, supplement and bioscience research combines perfectly with our expertise at Clasado. We are confident that he will make great contributions to our continued growth and we’re excited to see him drive the business forward.”

To find out more about Clasado Biosciences, please visit www.clasado.com